SPONSOR
Chiesi Farmaceutici S.p.A.
Total Trials
3
Recruiting
3
Phases
Phase 3
Conditions studied: Generalised LipodystrophyPartial LipodystrophyFamilial Partial LipodystrophyChronic Obstructive Pulmonary Disease
Chiesi Farmaceutici S.p.A. is a clinical research sponsor with 3 registered studies on ClinicalTrials.gov, of which 3 are actively recruiting participants. Research covers conditions including Generalised Lipodystrophy, Partial Lipodystrophy, Familial Partial Lipodystrophy, Chronic Obstructive Pulmonary Disease.
The trial portfolio spans Phase 3 studies, reflecting a pipeline that may include early-stage safety evaluations, mid-stage efficacy assessments, and large-scale confirmatory trials. All studies listed here are sourced directly from ClinicalTrials.gov and updated daily.
Frequently Asked Questions — Chiesi Farmaceutici S.p.A.
How many clinical trials has Chiesi Farmaceutici S.p.A. sponsored?
ClinicalMetric currently tracks 3 clinical trials sponsored by Chiesi Farmaceutici S.p.A., of which 3 are actively recruiting participants. These trials cover conditions including Generalised Lipodystrophy, Partial Lipodystrophy, Familial Partial Lipodystrophy. Trial counts are updated daily from ClinicalTrials.gov and reflect currently registered studies.
What therapeutic areas does Chiesi Farmaceutici S.p.A. research focus on?
Chiesi Farmaceutici S.p.A. clinical trials span Generalised Lipodystrophy, Partial Lipodystrophy, Familial Partial Lipodystrophy, Chronic Obstructive Pulmonary Disease. The research pipeline includes Phase 3 trials, reflecting work from early-stage safety evaluation through large-scale efficacy studies.
How do I participate in a Chiesi Farmaceutici S.p.A. clinical trial?
To participate in a Chiesi Farmaceutici S.p.A. trial, review the active studies listed on this page, check each trial's specific eligibility criteria on ClinicalTrials.gov, and contact the trial site directly—not the sponsor's headquarters. Trial sites are academic medical centers, hospitals, or specialized research clinics. Your physician can facilitate a referral. ClinicalMetric lists all Chiesi Farmaceutici S.p.A. trials with current recruitment status updated daily.
Clinical Trials by Chiesi Farmaceutici S.p.A.
NCT02325674
Recruiting
MEASuRE: Metreleptin Effectiveness And Safety Registry
Generalised Lipodystrophy
NCT06679270 Phase 3
Recruiting
Open-label Extension Study to Evaluate Metreleptin in Patients With Partial Lipodystrophy
Familial Partial Lipodystrophy
NCT05652439
Recruiting
PASS to Assess Cardiovascular and Cerebrovascular Events in COPD Patients Initiating Fixed Triple Therapy (DPI or pMDI)
Chronic Obstructive Pulmonary Disease
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: July 2026 · Data Methodology